GRAFT FAILURE

Clinical trials for GRAFT FAILURE explained in plain language.

Never miss a new study

Get alerted when new GRAFT FAILURE trials appear

Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 2 Completed 3 Terminated 1

Drug aimed at fixing bone marrow after transplant falls short in early trial

Disease control Terminated

This study tested a drug called eltrombopag to help people whose bone marrow doesn't recover well after a stem cell transplant for leukemia. The goal was to raise platelet counts and reduce the need for transfusions. The trial was stopped early after enrolling only 9 participants…

Matched conditions: GRAFT FAILURE

Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

GRAFT FAILURE

Get alerted when new GRAFT FAILURE trials appear

Drug aimed at fixing bone marrow after transplant falls short in early trial